InspireMD Inc
For the period ended Dec 31, 2023. Filed Mar 5, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 5, 2024
NSPR$0.78+9.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
Documents filed as part of report:
- Financial Statements
The following financial statements are included herein:
| ● | Report of Kesselman & Kesselman, Independent Registered Public Accounting Firm |
| ● | Consolidated Balance Sheets as of December 31, 2023 and 2022 |
| ● | Consolidated Statements of Operations for the Years Ended December 31, 2023 and 2022 |
| ● | Consolidated Statements of Changes in Equity for the Years Ended December 31, 2023 and 2022 |
| ● | Consolidated Statements of Cash Flows for the Years Ended December 31, 2023 and 2022 |
| ● | Notes to Consolidated Financial Statements |
- Financial Statement Schedules
None
- Exhibits
See Index to Exhibits
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.